Johnson & Johnson became the first company to add pricing information on pharmaceutical products being advertised on television. The anticoagulant Xarelto will soon have a list price and out-of-pocket cost in commercials.
Public Health February 9, 2019
The FDA didn't show any love for Johnson & Johnson on Friday, Feb. 14, denying the pharmaceutical major's application for the expanded use of the anticoagulant drug Xarelto for the third time.
Life February 17, 2014